TRAVERE THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$61M
Free Cash Flow
$61M
Investing Cash Flow↑+87.7% +$40M
$87M
Financing Cash Flow↓-80.8% -$112M
$27M
Capex
$140K
Acquisitions
—
Stock Buybacks
—
Stock-Based Comp↑+24.4% +$2M
$11M
Debt Repaid
—
D&A↑+50.0% +$6M
$18M
SBC Allocated Expense↑+24.4% +$2M
$11M
SBC Unrecognized Cost
—